Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 1, 2006, Pages 13-17

  Ishih, Akira ^a   Suzuki, Tohru ^a   Muregi, Francis W ^a,b   Matsui, Kae ^a   Terada, Mamoru ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744481012     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Beaute-Lafitte A, Altemayer-Caillard V, Gonnet-Gonzalez F, Ramiaramanana L, Chabaud AG, Landau I. The chemosensitivity of the rodent malarias- Relationships with the biology of merozoites. Int J Parasitol 1994; 24: 981-6.
2. Bitonti AJ, McCann PP. Desipramine and cyproheptadine for reversal of chloroquine resistance in Plasmodium falciparum. Lancet 1989; II: 1282-3.
3. Cambie G, Caillard V, Beaute-Lafitte A, Ginsburg H, Chabaud AG, Landau I. Chronotherapy of malaria: identification of drug sensitive stage of parasite and timing of drug delivery for improved therapy. Ann Parasitol Hum Comp 1991; 66: 14-21.
4. Ishih A, Suzuki T, Watanabe M, Miyase T, Terada M. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infected with chloroquine-resistant Plasmodium berghei NK65 in ICR mice. Phytother Res 2003; 17: 1234-6.
5. Ishih A, Suzuki T, Hasegawa T, Kachi S, Wang H-H, Terada M. In vivo evaluation of combination effects of chloroquine with Cepharantin or minocycline hydrochloride against blood-induced chloroquine-resistant Plasmodium berghei NK65 infection. Trop Med Health 2004; 32: 15-9.
6. Kyle DE, Milhous WK, Rossan RN. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. Am J Trop Med Hyg 1993; 48: 126-33.
7. Landau I, Gautret P. Animal models: Rodents. In: Sherman IW, ed. Malaria: parasite biology, pathogenesis, and protection. Washington, DC ASM Press, 1998: 401-17.
8. Landau I, Cambie G, Chabaud AG. Biology of Plasmodium merozoites with special reference to the chemoresistance of Plasmodium falciparum. Ann Parasitol Hum Comp 1990; 65: 101-3.
9. Lin Q, Katakura K, Oue M, Kano S, Suzuki M. Effects of minocycline against mefloquine-, chloroquine- and pyrimethamine-resistant Plasmodium falciparum in vitro. Jpn J Trop Med Hyg 2001; 29: 343-8.
10. Martin SK, Oduola AM, Milhous WK. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 1987; 235: 899-901.
11. Peters W. Drug resistance in malaria parasites of animals and man. Adv Parasitol 1998; 41: 1-62.
12. Peters W, Portus JH, Robinson BL. The chemotherapy of rodent malaria, XXII The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol 1975; 69: 155-71.
13. Peters W, Ekong R, Robinson BL, Warhurst DC, Pan X-Q. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. Ann Trop Med Parasitol 1990; 84: 541-51.
14. Stevenson MM. Genetic control of host resistance to malaria. In: Stevenson MM, ed. Malaria: host responses to infection. Boca Raton, Fla: CRC Press, 1989: 147-61.
15. White NJ, Olliaro PL. Strategies for the prevention of antimalarial drug resistance: Rationale for comnination chemotherapy for malaria. Parasitol Today 1996; 12: 399-401.